Arcadia Biosciences Inc (FRA:17D)
€ 3.72 (0%) Market Cap: 1.17 Mil Enterprise Value: -2.67 Mil PE Ratio: 0 PB Ratio: 0.40 GF Score: 43/100

Arcadia Biosciences Inc Annual Shareholders Meeting Transcript

Dec 19, 2025 / 07:00PM GMT
Release Date Price: €3.72
Kevin Comcowich
Arcadia Biosciences Inc - Independent Chairman of the Board

Good morning, ladies and gentlemen. I'm Kevin Comcowich, Chairman of the Board of Directors of Arcadia Biosciences, and it's my pleasure to welcome you to Arcadia Biosciences Annual Meeting of Stockholders. I'll act as Chair of this meeting and I've asked TJ Schaefer, our Chief Executive Officer and Corporate Secretary, to record the minutes of this meeting.

Before proceeding further, let me introduce the Directors and Director Nominees of the company: Lilian Shackelford Murray, Director and Nominee; Amy Yoder, Director and Nominee, Al Bolles, Director; Debbie Carosella, Director; Greg Waller, Director; TJ Schaefer, President, CEO, and Director.

I'd also like to introduce the corporate officers and company executives and certain other persons who are on the call. TJ Schaefer, our Chief Executive Officer, will also be serving as our Inspector of Elections, and Shannon Schroeder will be representing Deloitte & Touche, our independent registered public accountants.

I'll now turn the meeting over to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot